These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

857 related items for PubMed ID: 10718823

  • 1. Association of thyrotrophin receptor antibodies with the clinical features of Graves' ophthalmopathy.
    Gerding MN, van der Meer JW, Broenink M, Bakker O, Wiersinga WM, Prummel MF.
    Clin Endocrinol (Oxf); 2000 Mar; 52(3):267-71. PubMed ID: 10718823
    [Abstract] [Full Text] [Related]

  • 2. Clinical results of anti-inflammatory therapy in Graves' ophthalmopathy and association with thyroidal autoantibodies.
    Eckstein AK, Plicht M, Lax H, Hirche H, Quadbeck B, Mann K, Steuhl KP, Esser J, Morgenthaler NG.
    Clin Endocrinol (Oxf); 2004 Nov; 61(5):612-8. PubMed ID: 15521965
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Thyroid-stimulating antibody is related to Graves' ophthalmopathy, but thyrotropin-binding inhibitor immunoglobulin is related to hyperthyroidism in patients with Graves' disease.
    Noh JY, Hamada N, Inoue Y, Abe Y, Ito K, Ito K.
    Thyroid; 2000 Sep; 10(9):809-13. PubMed ID: 11041459
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. The combination of absent thyroid peroxidase antibodies and high thyroid-stimulating immunoglobulin levels in Graves' disease identifies a group at markedly increased risk of ophthalmopathy.
    Khoo DH, Ho SC, Seah LL, Fong KS, Tai ES, Chee SP, Eng PH, Aw SE, Fok AC.
    Thyroid; 1999 Dec; 9(12):1175-80. PubMed ID: 10646655
    [Abstract] [Full Text] [Related]

  • 8. Further evaluation of an immunoprecipitation assay for TSH-receptor autoantibodies in Graves' disease.
    De Bruin TW, Braverman LE, Brown RS.
    Metabolism; 1986 Dec; 35(12):1101-5. PubMed ID: 2878349
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Endocrine ophthalmopathy: a re-evaluation of the association with thyroid autoantibodies.
    McLachlan SM, Bahn R, Rapoport B.
    Autoimmunity; 1992 Dec; 14(2):143-8. PubMed ID: 1363894
    [Abstract] [Full Text] [Related]

  • 11. Studies on thyrotrophin receptor antibodies in patients with euthyroid Graves' disease.
    Kasagi K, Hatabu H, Tokuda Y, Iida Y, Endo K, Konishi J.
    Clin Endocrinol (Oxf); 1988 Oct; 29(4):357-66. PubMed ID: 2908031
    [Abstract] [Full Text] [Related]

  • 12. Clinical significance of classification of Graves' disease according to the characteristics of TSH receptor antibodies.
    Kim WB, Chung HK, Park YJ, Park DJ, Lee HK, Cho BY.
    Korean J Intern Med; 2001 Sep; 16(3):187-200. PubMed ID: 11769578
    [Abstract] [Full Text] [Related]

  • 13. Clinical value of a new TSH binding inihibitory activity assay using human TSH receptors in the follow-up of antithyroid drug treated Graves' disease. Comparison with thyroid stimulating antibody bioassay.
    Maugendre D, Massart C.
    Clin Endocrinol (Oxf); 2001 Jan; 54(1):89-96. PubMed ID: 11167931
    [Abstract] [Full Text] [Related]

  • 14. Clinical value of functional thyrotropin receptor antibodies in Serbian patients with Graves' orbitopathy.
    Sarić Matutinović M, Diana T, Nedeljković Beleslin B, Ćirić J, Žarković M, Kahaly GJ, Ignjatović S.
    J Endocrinol Invest; 2022 Jan; 45(1):189-197. PubMed ID: 34324163
    [Abstract] [Full Text] [Related]

  • 15. Demonstration of anti-TSH antibody in TSH binding inhibitory immunoglobulin-positive sera of patients with Graves' disease.
    Ochi Y, Hamazu M, Kajita Y, Nagata A.
    Clin Endocrinol (Oxf); 2002 Mar; 56(3):405-12. PubMed ID: 11940054
    [Abstract] [Full Text] [Related]

  • 16. Evaluation of TSH receptor antibody by 'natural in vivo human assay' in neonates born to mothers with Graves' disease.
    Tamaki H, Amino N, Iwatani Y, Tachi J, Kimura M, Mitsuda N, Ichihara K, Tanizawa O, Miyai K.
    Clin Endocrinol (Oxf); 1989 May; 30(5):493-503. PubMed ID: 2575017
    [Abstract] [Full Text] [Related]

  • 17. Thyroid autoantibody profiles in ophthalmic dominant and thyroid dominant Graves' disease differ and suggest ophthalmopathy is a multiantigenic disease.
    Goh SY, Ho SC, Seah LL, Fong KS, Khoo DH.
    Clin Endocrinol (Oxf); 2004 May; 60(5):600-7. PubMed ID: 15104563
    [Abstract] [Full Text] [Related]

  • 18. Assays for thyroid-stimulating antibodies and thyrotropin-binding inhibitory immunoglobulins in children with Graves' disease.
    Shibayama K, Ohyama Y, Yokota Y, Ohtsu S, Takubo N, Matsuura N.
    Endocr J; 2005 Oct; 52(5):505-10. PubMed ID: 16284425
    [Abstract] [Full Text] [Related]

  • 19. A bioluminescence assay for thyrotropin receptor antibodies predicts serum thyroid hormone levels in patients with de novo Graves' disease.
    Hovens GC, Buiting AM, Karperien M, Ballieux BE, van der Pluijm G, Pereira AM, Romijn JA, Smit JW.
    Clin Endocrinol (Oxf); 2006 Apr; 64(4):429-35. PubMed ID: 16584516
    [Abstract] [Full Text] [Related]

  • 20. Immunoglobulins of untreated Graves' patients with or without thyrotropin receptor antibody (determined by porcine thyrocytes) universally elicit potent thyroid hormone-releasing activity in cultured human thyroid follicles.
    Sato K, Yamazaki K, Yamada E, Kanaji Y, Miura M, Obara T.
    Thyroid; 1999 Oct; 9(10):979-88. PubMed ID: 10560951
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 43.